M

Medicalgorithmics SA
WSE:MDG

Watchlist Manager
Medicalgorithmics SA
WSE:MDG
Watchlist
Price: 33.85 PLN -0.29% Market Closed
Market Cap: 336.8m PLN

Medicalgorithmics SA
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Medicalgorithmics SA
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicalgorithmics SA
WSE:MDG
Free Cash Flow
-zł5.3m
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
N/A
S
Sds Optic SA
WSE:SDS
Free Cash Flow
-zł8.8m
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Scope Fluidics SA
WSE:SCP
Free Cash Flow
-zł47.9m
CAGR 3-Years
10%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
M
Medinice SA
WSE:ICE
Free Cash Flow
-zł11.9m
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
N
Nestmedic SA
WSE:NST
Free Cash Flow
-zł5.6m
CAGR 3-Years
19%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
I
Inventionmed SA
WSE:INM
Free Cash Flow
-zł2.3m
CAGR 3-Years
16%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
No Stocks Found

Medicalgorithmics SA
Glance View

Market Cap
336.9m PLN
Industry
Health Care

Medicalgorithmics SA engages in the development of mobile electrocardiogram and arrhythmia diagnostic technology. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 329 full-time employees. The company went IPO on 2011-11-09. The firm develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). The company operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.

MDG Intrinsic Value
23.56 PLN
Overvaluation 30%
Intrinsic Value
Price
M

See Also

What is Medicalgorithmics SA's Free Cash Flow?
Free Cash Flow
-5.3m PLN

Based on the financial report for Sep 30, 2025, Medicalgorithmics SA's Free Cash Flow amounts to -5.3m PLN.

What is Medicalgorithmics SA's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-28%

Over the last year, the Free Cash Flow growth was 58%.

Back to Top